These results suggest that KL-6 has a potent inhibitory effect on the clonogenic potential of pancreatic cancer cells, indicating its potential as a therapeutic agent in pancreatic cancer treatment. The gene discussed is MUC1; the disease is familial pancreatic carcinoma.